United States Biotechnology & Medical Research

LungLife AI Inc (LLAI)

LungLife AI Inc has recorded no insider trading activity within the past three months. The most recent transactions occurred on August 14, 2023, when the Chief Financial Officer and Chief Executive Officer each purchased 12,123 shares. These historical acquisitions represent the final documented market movements by company leadership.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: LLAI Exchange: LSE

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for LungLife AI Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

David Anderson Chief Financial Officer Officer

Transaction date 14 Aug 2023

Purchase

Price

12.68

Quantity 14,954

Value £4,209,332

Paul Pagano Chief Executive Officer Officer

Transaction date 14 Aug 2023

Purchase

Price

351.77

Quantity 96,030

Value £264,634

David Anderson Chief Financial Officer Officer

Transaction date 11 Feb 2022

Purchase

Price

155.06

Quantity 61,099

Value £4,901,800

Paul Pagano Chief Executive Officer Officer

Transaction date 11 Feb 2022

Purchase

Price

1.30

Quantity 5,000

Value £6,500

Andrew Boteler Non-Executive Director Executive Director

Transaction date 8 Jul 2021

Purchase

Price

1.76

Quantity 5,681

Value £9,999

Roy Davis Non-Executive Chairman Director

Transaction date 8 Jul 2021

Purchase

Price

1.76

Quantity 14,204

Value £24,999

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-08-14	2023-08-14	B Purchase	David Anderson Chief Financial Officer Officer	14,954 12.68 £4,209,332	14,954	12.68	£4,209,332
2023-08-14	2023-08-14	B Purchase	Paul Pagano Chief Executive Officer Officer	96,030 351.77 £264,634	96,030	351.77	£264,634
2022-11-03	2022-02-11	B Purchase	David Anderson Chief Financial Officer Officer	61,099 155.06 £4,901,800	61,099	155.06	£4,901,800
2022-11-03	2022-02-11	B Purchase	Paul Pagano Chief Executive Officer Officer	5,000 1.30 £6,500	5,000	1.30	£6,500
2021-07-08	2021-07-08	B Purchase	Andrew Boteler Non-Executive Director Executive Director	5,681 1.76 £9,999	5,681	1.76	£9,999
2021-07-08	2021-07-08	B Purchase	Roy Davis Non-Executive Chairman Director	14,204 1.76 £24,999	14,204	1.76	£24,999